Holdings (Monthly)
Guide ↗
BlackRock Health Sciences Opportunities Portfolio
· BlackRock Funds| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UNITEDHEALTH GROUP INC | UNH | Feb 2026 | 947,412 | +269,501 | $360.3M | +81.2% | 6.10% | EC |
| 2 | MERCK & COMPANY INC | MRK | Feb 2026 | 2,456,466 | +584,660 | $291.6M | +25.8% | 4.94% | EC |
| 3 | GILEAD SCIENCES INC | GILD | Feb 2026 | 1,841,333 | +104,911 | $247.5M | -4.3% | 4.19% | EC |
| 4 | AMGEN INC | AMGN | Feb 2026 | 590,203 | +2,045 | $198.8M | -12.9% | 3.37% | EC |
| 5 | THERMO FISHER SCIENTIFIC INC | TMO | Feb 2026 | 362,337 | +77,051 | $178.5M | +20.0% | 3.02% | EC |
| 6 | VERTEX PHARMACEUTICALS INC | VRTX | Feb 2026 | 361,907 | +88,589 | $162.0M | +19.3% | 2.74% | EC |
| 7 | PFIZER INC | PFE | Feb 2026 | 5,899,018 | +4,714,396 | $154.4M | +371.5% | 2.61% | EC |
| 8 | BOSTON SCIENTIFIC CORP | BSX | Feb 2026 | 1,945,032 | +660,670 | $94.0M | -4.8% | 1.59% | EC |
| 9 | ELEVANCE HEALTH INC | ELV | Feb 2026 | 234,947 | +146,342 | $92.4M | +225.8% | 1.56% | EC |
| 10 | ASTRAZENECA PLC | AZN | Feb 2026 | 384,355 | +236,566 | $71.4M | +1.5% | 1.21% | EC |
| 11 | BLACKROCK FUNDS III | BISXX | Feb 2026 | 59,490,958 | +2,055,537 | $59.5M | +3.6% | 1.01% | STIV |
| 12 | REVOLUTION MEDICINES INC | RVMD | Feb 2026 | 361,340 | +58,345 | $56.9M | +84.1% | 0.96% | EC |
| 13 | HUMANA INC | HUM | Feb 2026 | 178,205 | +99,512 | $54.4M | +263.0% | 0.92% | EC |
| 14 | COGENT BIOSCIENCES INC | COGT | Feb 2026 | 1,406,858 | +586,439 | $49.2M | +54.3% | 0.83% | EC |
| 15 | CYTOKINETICS INC | CYTK | Feb 2026 | 575,188 | +390,411 | $44.2M | +284.0% | 0.75% | EC |
| 16 | INSMED INC | INSM | Feb 2026 | 392,149 | +90,796 | $41.9M | -6.8% | 0.71% | EC |
| 17 | CVS HEALTH CORP | CVS | Feb 2026 | 459,705 | +100,423 | $41.8M | +45.7% | 0.71% | EC |
| 18 | APOGEE THERAPEUTICS INC | APGE | Feb 2026 | 263,702 | +60,752 | $21.7M | +52.5% | 0.37% | EC |
| 19 | NEUROCRINE BIOSCIENCES INC | NBIX | Feb 2026 | 113,005 | +34,284 | $17.9M | +71.8% | 0.30% | EC |
| 20 | DIANTHUS THERAPEUTICS INC | DNTH | Feb 2026 | 186,482 | +78,449 | $17.3M | +190.9% | 0.29% | EC |
| 21 | ORUKA THERAPEUTICS INC | ORKA | Feb 2026 | 264,813 | +79,798 | $15.5M | +143.5% | 0.26% | EC |
| 22 | ARCUS BIOSCIENCES INC | RCUS | Feb 2026 | 572,430 | +116,888 | $14.5M | +56.3% | 0.25% | EC |
| 23 | INTELLIA THERAPEUTICS INC | NTLA | Feb 2026 | 664,846 | +146,454 | $9.4M | +31.0% | 0.16% | EC |
| 24 | VAXCYTE INC | PCVX | Feb 2026 | 147,352 | +59,812 | $7.6M | +40.1% | 0.13% | EC |
| 25 | METTLER-TOLEDO INTERNATIONAL INC | MTD | Feb 2026 | 6,058 | +1,464 | $7.2M | +13.9% | 0.12% | EC |